A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples